Towards a Three-Dimensional Microfluidic in vitro Model to Assess Efficacy & Safety in Cancer Immunotherapy

Ramona Nudischer(Roche (Switzerland)), Adrian Roth(Roche (Switzerland)), Andreas Hierlemann(ETH Zurich), Olivier Frey(Inspire), Kasper Renggli(Vectura (Germany)), Cristina Bertinetti‐Lapatki(Roche (Switzerland)), Christian Lohasz(ETH Zurich)
Unknown
January 1, 2017
Cited by 0


Related Papers